Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: opalapril who wrote (7469)	10/10/1998 7:16:00 PM
From: Bluegreen	Read Replies (1) \| Respond to of 17367

You don't think a Tucker was a good investment? Just go out and price a few, I think you will be MORE than shocked.

To: opalapril who wrote (7469)	10/11/1998 6:08:00 PM
From: aknahow	Respond to of 17367

opalapril, I probably agree more with you than you might think. The consolidation of biotechs will hepl new buyers not most of those that hold them now. I remember the Favorite Fifty theory which lasted longer than it was expected to. The dogs of the Dow strategy appears to have also suffered from over popularity. In fact one can say that the fact that small caps consistently outperformed large caps until about 97 (?) indicates nothing last forever. Many have nothing but a negative attitude toward biotechs. They have few friends. Funding is a real problem. I do wonder if the U.S. is prepared to let this segment go under. While I obviously don't have the solution to regulatory reform I think some sort of reform could reduce the financial burden of discovery. This may or may not occur. Even without it I still think those biotechs that come up with new approvals for drugs that have potentially large markets will do well. I think there has been capitulation in this market segment. I don't know or can't even guess when a rebound will start.